Phase I clinical trial of a new antitumor agent, 4'-demethylepipodophyllotoxin 9-(4,6-O-ethylidene- -D-glucopyranoside) (NSC-141540; VP-16-213).

Authors:
  • NNN I Nissen
    N I Nissen
  • VLV Larsen
    V Larsen
  • HPH Pedersen
    H Pedersen
  • KTK Thomsen
    K Thomsen

  • 1 December 1972
    • journal article
    • clinical trial
    • Vol. 56  (6) , 769-77
    • PMID:4634038
Abstract
No abstract available